Kaia Health, a global leader in digital therapeutics for chronic disease management, today announced a new collaboration with MedImprove, a leading private lung rehabilitation clinic, to launch a ...
MedPage Today on MSN
Mucus-Thinning Strategies Fail for Bronchiectasis, Study Shows
Mucoactive agents did little to stave off pulmonary exacerbations of non-cystic fibrosis bronchiectasis, the CLEAR trial ...
Lucknow: A simple blood test every three months could save the lives of Chronic Obstructive Pulmonary Disease (COPD) patients ...
In a new study, Yale School of Medicine (YSM) researchers unveiled a novel diagnostic method for detecting leptospiral ...
Pulmonary fibrosis is a lung disease where the air sacs and tissue in the lungs get stiff and scarred. This makes it harder to breathe and perform everyday activities. The ...
Savara Inc. (the "Company") (Nasdaq: SVRA), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, ...
A new project led by Oxford University aims to develop a novel breathing test that could detect asthma and COPD earlier, more ...
4don MSN
Tiniest lung tumors that are hardest to reach can be diagnosed with robot-assisted bronchoscope
A cutting-edge bronchoscope that is guided with the help of a robot can reach very small tumors growing in hard-to-reach ...
US FDA assent for 4D Medical’s CT VQ ventilation perfusion device described by the company as a “transformational milestone”.
A huge portion of my practice of medicine involves the prevention of what are often called “silent killers” — hypertension, ...
Affinity Technologies shares 3 new case studies in which CyPath Lung detected Stage 1A lung cancer or prevented unnecessary ...
Investing.com -- Bioaffinity Technologies Inc (NASDAQ:BIAF) stock soared 79% in premarket trading Friday after the biotechnology company released three new case studies highlighting the effectiveness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results